FOR PATIENTS

Be Part of Generation G

Join the nearly 30,000 people with relapsing forms of
multiple sclerosis who have been prescribed Glatopa®1

Not actual patients.
 

Glatopa gives you a quality treatment at an affordable cost

Glatopa is an FDA-approved generic substitute for COPAXONE® (glatiramer acetate injection).2 This means that Glatopa:

  • Has the same active ingredient and dosage strength options
  • Meets the same FDA quality standards
  • Delivers the same therapeutic results

The difference with Glatopa is that it costs a lot less.3

 

Glatopa gives you 2 dosing options and the freedom to choose what works for you

Glatopa 20 mg/mL is taken once a day, and has been prescribed for nearly 30,000 people since 20151,4

Glatopa 40mg/mL is taken 3 times a week, giving you more injection-free days (209 less injections each year!)4

Learn more about your dosing options
 

GlatopaCare® gives you a team of support every step of the way

GlatopaCare® is a free program that connects you and your family to one-on-one support. Here’s how your GlatopaCare® team can help.

See if you're eligible* for a $0 co-pay on your monthly Glatopa prescriptions

Learn more about what your insurance and benefits may cover

Connect to nurse support anytime, day or night

Get injection training in your home or over the phone

Learn more about GlatopaCare®
 

Enroll in GlatopaCare® today

3 ways to enroll in the program. Pick the one that is easiest for you.

1

Click here to enroll online

OR
2

Call 1-855-GLATOPA (1-855-452-8672)

OR
3

Text “START” to 23519

 

*Glatopa Co-Pay Program Eligibility

The Glatopa Co-Pay Program provides up to $9000 in annual co-pay support for Glatopa prescriptions. This program is not health insurance. This program is for insured patients only; uninsured cash-paying patients are not eligible. Patients are not eligible if prescriptions are paid, in whole or in part, by any state or federally funded programs, including but not limited to Medicare (including Part D, even in the coverage gap) or Medicaid, Medigap, VA, DOD, or TriCare, or private indemnity, or HMO insurance plans that reimburse you for the entire cost of your prescription drugs, or where prohibited by law. Card may not be combined with any other rebate, coupon, or offer. Card has no cash value. Sandoz reserves the right to rescind, revoke, or amend this offer without further notice.

Indication

Glatopa® (glatiramer acetate injection) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Important Safety Information

Do not take Glatopa® if you are allergic to glatiramer acetate, mannitol, or any of the ingredients in Glatopa.

Some patients report a short-term reaction right after or within minutes after injecting glatiramer acetate. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain, fast heartbeat, anxiety, and trouble breathing. These symptoms generally appear within seconds to minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again.

Chest pain may occur either as part of the immediate post-injection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain that lasts for a long time or feels very intense.

A permanent indentation under the skin (lipoatrophy) or, rarely, necrosis at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.

Liver problems, including liver failure, can occur with Glatopa. Call your healthcare provider right away if you have symptoms, such as: nausea, loss of appetite, tiredness, dark colored urine and pale stools, yellowing of your skin or the white part of your eye, bleeding more easily than normal, confusion, sleepiness.

The most common side effects in studies of glatiramer acetate injection are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of glatiramer acetate. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking Glatopa.

To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see full Prescribing Information for Glatopa.

References

1. Data on file [IMS SMART data]. Princeton, NJ: Sandoz Inc; 2020 2. US Department of Health Services. Orange Book: Approved drug products with therapeutic equivalence evaluations. https://www.fda.gov/media/71474/download. Accessed November 29, 2021. 3. Data on file. Red Book. Sandoz Inc. January 2022. 4. Glatopa Prescribing Information. Sandoz Inc. July 2020.